We have advised Nuritas, a Dublin-based biotech specialising in AI-driven peptide discovery, on securing a $42 million funding round. The financing will enable Nuritas to scale its operations, expand its global customer base, and reach more consumers worldwide.

Our team was led by Sophie Frederix (Corporate and M&A) and included Tim Gleeson, Jack Connaughton, Sydney O’Shea and Emma Kennedy (Corporate and M&A).

Read more here.